22 results
DEF 14C
BGLC
BioNexus Gene Lab Corp
29 Feb 24
Information statement
5:16pm
Committee is charged with the responsibility of reviewing our corporate governance policies and with proposing potential director nominees … management of risks the Company faces, while the Board as a whole has ultimate responsibility for the Company’s oversight of risk management. Our Board
PRE 14C
BGLC
BioNexus Gene Lab Corp
26 Jan 24
Preliminary information
4:05pm
Committee is charged with the responsibility of reviewing our corporate governance policies and with proposing potential director nominees to the Board … the Board as a whole has ultimate responsibility for the Company’s oversight of risk management. Our Board takes an enterprise-wide approach to risk
8-K
EX-1.1
BGLC
BioNexus Gene Lab Corp
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
) no Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to any of the transactions
8-K
EX-3.1
BGLC
BioNexus Gene Lab Corp
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
of authority shall operate to relieve the board or any director from any responsibility imposed by law. The board shall at any time have the power to fill
424B4
0uty6att moeq3r0
21 Jul 23
Prospectus supplement with pricing info
3:37pm
8-K/A
EX-99.1
9jdxr8ww m60mvdq
11 Mar 21
Index to the Audited Financial Statements
3:54pm
10-K
zdfhxip9k gge
31 Mar 20
Annual report
1:12pm
CORRESP
2x00sbl
2 Apr 19
Correspondence with SEC
12:00am
CORRESP
tw8bd2m3
2 Apr 19
Correspondence with SEC
12:00am
S-1/A
iys wefdz9ujati42t0
25 Feb 19
IPO registration (amended)
3:30pm